GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy
This study is currently recruiting participants.
Verified November 2011 by Sandoz
Sponsor:
Sandoz
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Sandoz
ClinicalTrials.gov Identifier:
NCT01274182
First received: January 10, 2011
Last updated: November 11, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |